253 related articles for article (PubMed ID: 30703546)
41. Novel telemetric system for extraluminal measurement of gastrointestinal motility.
Shearin NL; Pfeiffer CJ; Kilam S
J Appl Physiol; 1976 Sep; 41(3):425-8. PubMed ID: 965313
[TBL] [Abstract][Full Text] [Related]
42. Assessment of the variation associated with repeated measurement of gastrointestinal transit times and assessment of the effect of oral ranitidine on gastrointestinal transit times using a wireless motility capsule system in dogs.
Lidbury JA; Suchodolski JS; Ivanek R; Steiner JM
Vet Med Int; 2012; 2012():938417. PubMed ID: 22792515
[TBL] [Abstract][Full Text] [Related]
43. Ingestible devices for studying the gastrointestinal physiology and their application in oral biopharmaceutics.
Weitschies W; Müller L; Grimm M; Koziolek M
Adv Drug Deliv Rev; 2021 Sep; 176():113853. PubMed ID: 34192551
[TBL] [Abstract][Full Text] [Related]
44. [Motility-recording capsule simplifies gastrointestinal examination. Safe diagnostics in motility disorders].
Diaz H; Sjöström U; Lindberg G; Hellström PM
Lakartidningen; 2016 Apr; 113():. PubMed ID: 27070390
[TBL] [Abstract][Full Text] [Related]
45. Regional gastrointestinal transit times in severe ulcerative colitis.
Haase AM; Gregersen T; Christensen LA; Agnholt J; Dahlerup JF; Schlageter V; Krogh K
Neurogastroenterol Motil; 2016 Feb; 28(2):217-24. PubMed ID: 26729638
[TBL] [Abstract][Full Text] [Related]
46. Effect of endotoxin on canine gastrointestinal motility and transit.
Cullen JJ; Caropreso DK; Ephgrave KS
J Surg Res; 1995 Jan; 58(1):90-5. PubMed ID: 7830412
[TBL] [Abstract][Full Text] [Related]
47. Gastric pH and gastric residence time in fasted and fed conscious beagle dogs using the Bravo pH system.
Mahar KM; Portelli S; Coatney R; Chen EP
J Pharm Sci; 2012 Jul; 101(7):2439-48. PubMed ID: 22531871
[TBL] [Abstract][Full Text] [Related]
48. The use of a wireless motility device (SmartPill®) for the measurement of gastrointestinal transit time after a dietary fibre intervention.
Timm D; Willis H; Thomas W; Sanders L; Boileau T; Slavin J
Br J Nutr; 2011 May; 105(9):1337-42. PubMed ID: 21138605
[TBL] [Abstract][Full Text] [Related]
49. Neonatal gastric motility in dogs: maturation and response to pentagastrin.
Malloy MH; Morriss FH; Denson SE; Weisbrodt NW; Lichtenberger LM; Adcock EW
Am J Physiol; 1979 May; 236(5):E562-6. PubMed ID: 35982
[TBL] [Abstract][Full Text] [Related]
50. Acute and chronic effects of desvenlafaxine on gastrointestinal transit and motility in dogs.
Song J; Yin J; Chen JD
Neurogastroenterol Motil; 2013 Oct; 25(10):824-e637. PubMed ID: 23865827
[TBL] [Abstract][Full Text] [Related]
51. Gastrointestinal physiology-regulated dogs for bioavailability evaluation of an oral controlled-release dosage form composed of pulsatile release granules.
Sagara K; Yamada I; Matsuura Y; Kawata M; Shibata M
Biol Pharm Bull; 1996 Sep; 19(9):1184-8. PubMed ID: 8889038
[TBL] [Abstract][Full Text] [Related]
52. Utility of animal gastrointestinal motility and transit models in functional gastrointestinal disorders.
Al-Saffar A; Takemi S; Saaed HK; Sakata I; Sakai T
Best Pract Res Clin Gastroenterol; 2019; 40-41():101633. PubMed ID: 31594654
[TBL] [Abstract][Full Text] [Related]
53. pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model.
Zhou R; Moench P; Heran C; Lu X; Mathias N; Faria TN; Wall DA; Hussain MA; Smith RL; Sun D
Pharm Res; 2005 Feb; 22(2):188-92. PubMed ID: 15783065
[TBL] [Abstract][Full Text] [Related]
54. Population In Vitro-In Vivo Correlation Model Linking Gastrointestinal Transit Time, pH, and Pharmacokinetics: Itraconazole as a Model Drug.
Abuhelwa AY; Mudge S; Hayes D; Upton RN; Foster DJ
Pharm Res; 2016 Jul; 33(7):1782-94. PubMed ID: 27119846
[TBL] [Abstract][Full Text] [Related]
55. A portable method for assessing gastrointestinal motility by simultaneously measuring transit time and contraction frequency.
Li H; Yan G
J Med Eng Technol; 2008; 32(6):448-55. PubMed ID: 19005962
[TBL] [Abstract][Full Text] [Related]
56. Effects of acepromazine and butorphanol on positive-contrast upper gastrointestinal tract examination in dogs.
Scrivani PV; Bednarski RM; Myer CW
Am J Vet Res; 1998 Oct; 59(10):1227-33. PubMed ID: 9781452
[TBL] [Abstract][Full Text] [Related]
57. Different absorption profiles of deramciclane in man and in dog.
Kanerva H; Klebovich I; Drabant S; Urtti A; Nevalainen T
J Pharm Pharmacol; 1998 Oct; 50(10):1087-93. PubMed ID: 9821653
[TBL] [Abstract][Full Text] [Related]
58. Simulating the postprandial stomach: physiological considerations for dissolution and release testing.
Koziolek M; Garbacz G; Neumann M; Weitschies W
Mol Pharm; 2013 May; 10(5):1610-22. PubMed ID: 23506381
[TBL] [Abstract][Full Text] [Related]
59. Effect of prolonged general anesthesia with sevoflurane and laparoscopic surgery on gastric and small bowel propulsive motility and pH in dogs.
Boscan P; Cochran S; Monnet E; Webb C; Twedt D
Vet Anaesth Analg; 2014 Jan; 41(1):73-81. PubMed ID: 24127667
[TBL] [Abstract][Full Text] [Related]
60. The relationship between gastrointestinal transit and motility in dogs with postoperative ileus.
Tsukamoto K; Mizutani M; Yamano M; Suzuki T
Biol Pharm Bull; 1999 Dec; 22(12):1366-71. PubMed ID: 10746171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
